Medical Marijuana, Inc. Announces the Launch of HempMeds® Mexico: Opening the Cannabidiol (CBD) Market to the Country’s More Than 122 Million Residents

Medical Marijuana, Inc.’s RSHO-XTM Hemp-Based Cannabidiol (CBD) Products Are Now Available For Import Into Mexico at HempMeds.MX

SAN DIEGO, Feb. 04, 2016 (GLOBE NEWSWIRE) -- It is with great excitement that Medical Marijuana, Inc. (OTC Pink:MJNA) announces the launch of HempMeds® Mexico to shareholders and the public. HempMeds® Mexico was created to provide access to CBD hemp oil products that are now legal to import in the country of Mexico for the first time.

“The Company is in the process of establishing a HempMeds® Mexico office in Monterrey, Mexico within the next week. Over the next year the Company will bring its lab, manufacturing, sales and distribution facilities to Mexico, in order to provide our products to all of the Latin America market, creating employment and an entirely new industry in Mexico,” stated Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc. According to a recent Reuters article, Mexico represents a “$1 billion to $2 billion opportunity in terms of cumulative revenue over the next 10 years.”

History was made on Tuesday, February 2, 2016 when the government of Mexico issued two of the country’s first permits to import the cannabidiol (CBD) product, Real Scientific Hemp OilTM called RSHO-XTM, from the Company.

The move by COFEPRIS (the Mexican health authority) has cleared the way for millions of individuals and families to access HempMeds® Mexico’s RSHO-XTM, a  non-psychoactive cannabidiol (CBD) hemp oil. RSHO-XTM is a CBD hemp oil product that is specific to the Mexico market.

“This is a giant step in the right direction, this historic decision will soon allow anyone in Mexico the freedom to import RSHO-XTM products, with a doctor’s prescription and import permit. It’s our mission to make cannabidiol products safe, and easily accessible to every person in Mexico,” said Titus.

Around the globe, cannabidiol (CBD) hemp oil is widely regarded as a “whole food” and “superfood.” MJNA’s cannabidiol is derived from the mature stalk of the hemp plant and is considered a food nutrient delivering the benefits of cannabinoids without the psychotropic/euphoric effects of Tetrahydrocannabinol (THC).

Although CBD hemp oil products from MJNA are readily available online in the U.S. as a “nutritional supplement” or “food product” and can be shipped to all 50 states, territories, and districts, hemp oil products are handled quite differently in Mexico and Brazil, which require a doctor’s prescription and import permit.

HempMeds® Mexico will be attending every national public debate throughout Mexico through April 5th, as the country determines how to change its laws to conform with the landmark Mexican Supreme Court cannabis ruling in November 2015.

HempMeds® Mexico will also continue to sponsor and hold events throughout the country. Along with our premier partner, the “Por Grace Foundation”, HempMeds® Mexico has already hosted two historic educational events, one in Mexico City and a second in Monterrey.

Details of the COFEPRIS announcement can be found here:

Additional information is listed on the HempMeds® Mexico website. For more information on RSHO-XTM, visit

About HempMeds® Mexico

HempMeds® Mexico is a Mexico-based company, created to provide access to cannabinoid-based products including cannabidiol (CBD) hemp oil products as they become legal in the country of Mexico for the first time. Our Company is a sales, marketing and distribution company. HempMeds® Mexico plans to work directly with the Mexican government to safely and legally provide access to our CBD hemp oil products. HempMeds® Mexico is the first company to legally ship RSHO-XTM CBD hemp oil into Mexico. For more information, please review the company’s website at:

About Medical Marijuana Inc.

The mission of Medical Marijuana, Inc. (OTC Pink:MJNA) is to be the premier hemp industry innovator, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company's website at:

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


Contact Data